Current health expenditure (CHE) per capita (US$) vs Oncology novel active substance (NAS) launches (cumulative) in China
Current health expenditure (CHE) per capita (US$) (annual) and Oncology novel active substance (NAS) launches (cumulative) (multi-month) in China. They are published at different intervals, so each is drawn on its own rather than matched period by period.
Change the pair
Compare different indicators
The series
Over time
China. Current health expenditure (CHE) per capita (US$) is published as annual figures and oncology novel active substance (NAS) launches (cumulative) as multi-month ones, so they are drawn on separate charts, clipped to 2015–2020, and no period is matched between them. Read each on its own.
Current health expenditure (CHE) per capita (US$)
Unit: USD · 6 observations
Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 2 observations
Shared periods
Side by side
No period lines up: current health expenditure (CHE) per capita (US$) is annual and oncology novel active substance (NAS) launches (cumulative) is multi-month. A month and a year are not the same measurement window, so no row pairs them.
Provenance
Where these numbers come from
Current health expenditure (CHE) per capita (US$)
Per capita current health expenditure expressed in US dollars, as published by the WHO Global Health Expenditure Database.
6 observations charted in China (of 24 annual records) · source organisations: WHO
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
2 observations charted in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring